Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia.
about
Add-on-Statin Extended Release Nicotinic Acid/Laropiprant but Not the Switch to High-Dose Rosuvastatin Lowers Blood Pressure: An Open-Label Randomized StudyCombination of niacin and fenofibrate with lifestyle changes improves dyslipidemia and hypoadiponectinemia in HIV patients on antiretroviral therapy: results of "heart positive," a randomized, controlled trial.Extended release niacin-laropiprant in patients with hypercholesterolemia or mixed dyslipidemias improves clinical parametersCardiovascular disease risk reduction by raising HDL cholesterol--current therapies and future opportunities.Emerging options in the treatment of dyslipidemias: a bright future?Combination lipid therapy in type 2 diabetes mellitus.Combination treatment with atorvastatin plus niacin provides effective control of complex dyslipidemias: a literature review.Nicotinic acid: clinical considerations.Prostanoids receptors signaling in different diseases/cancers progression.High-density Lipoprotein and Low-density Lipoprotein Therapeutic Approaches in Acute Coronary Syndromes.Attenuation of niacin-induced prostaglandin D(2) generation by omega-3 fatty acids in THP-1 macrophages and Langerhans dendritic cellsThe effect of niacin on serum phosphorus levels in dialysis patients.Optimizing lipid-lowering therapy in the prevention of coronary heart disease.
P2860
Q35072453-D14EA6C0-2F93-421B-9A84-B24CB60720F6Q35101789-2D6F6D35-524F-4B79-A5F9-E711249983BCQ35440499-18AFA3A9-32C2-4FD5-8CA7-799ABBB4FFE9Q36419283-78240DD4-517A-4708-A5C3-674153FD27D7Q37842462-75C73266-8F2D-45D3-A5FB-54042A07E817Q37842472-A50790EB-7079-42D2-9653-AFEB74C96071Q37982202-AE961BCA-3C2B-4D43-823C-E32986A114FFQ38008035-AA73ADC4-DF98-4190-8C48-CCEBEF27B2B4Q38074716-402CC8E6-F306-4126-9816-85B0B956200DQ38965138-B7D004E7-5C27-44D7-829C-504642BB80DCQ42575304-6C9D16C6-74C5-41B0-8254-7DB0369EBFC4Q42585296-A75ED37B-E584-4CCC-968F-FFD97291EB59Q53168850-7075D007-89DC-4D49-A714-FE32B85E407D
P2860
Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Review of extended-release nia ...... primary hypercholesterolemia.
@en
Review of extended-release nia ...... primary hypercholesterolemia.
@nl
type
label
Review of extended-release nia ...... primary hypercholesterolemia.
@en
Review of extended-release nia ...... primary hypercholesterolemia.
@nl
prefLabel
Review of extended-release nia ...... primary hypercholesterolemia.
@en
Review of extended-release nia ...... primary hypercholesterolemia.
@nl
P2860
P921
P356
P1476
Review of extended-release nia ...... primary hypercholesterolemia.
@en
P2093
Klaus G Parhofer
P2860
P304
P356
10.2147/VHRM.S4502
P407
P577
2009-11-16T00:00:00Z